INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	85,270	93,258	93,320	51,597	186,337	253,364
Market Cap Growth	22.17%	-0.07%	80.86%	-72.31%	-26.46%	119.86%
Enterprise Value	84,987	89,287	87,747	118,105	125,455	246,925
Last Close Price	8540.00	9340.00	9340.00	15500.00	71200.00	104800.00
PE Ratio	3.26	5.78	8.23	-	1.98	-
PS Ratio	10.93	13.25	14.95	4.95	17.78	24.80
PB Ratio	0.50	0.58	0.65	0.37	0.82	3.25
P/TBV Ratio	0.50	0.58	0.66	0.49	1.05	3.28
EV/Sales Ratio	10.89	12.68	14.06	11.34	11.97	24.17
Debt / Equity Ratio	0.00	0.01	0.00	0.01	0.06	0.06
Net Debt / Equity Ratio	0.00	-0.03	-0.04	-0.05	-0.04	-0.95
Net Debt / EBITDA Ratio	0.06	0.96	1.11	1.66	1.39	15.42
Net Debt / FCF Ratio	0.08	41.07	5.10	0.65	1.03	8.78
Asset Turnover	0.05	0.05	0.04	0.05	0.06	0.11
Inventory Turnover	32.50	12.99	4.10	5.61	6.94	6.01
Quick Ratio	2.91	4.32	4.90	3.92	1.07	4.66
Current Ratio	2.96	4.38	5.36	4.39	1.15	4.73
Return on Equity (ROE)	16.31%	10.64%	8.39%	-63.67%	61.55%	-62.65%
Return on Assets (ROA)	-2.11%	-2.47%	-2.66%	-1.78%	-2.74%	-3.50%
Return on Invested Capital (ROIC)	-3.31%	-4.16%	-4.57%	-3.41%	-6.22%	-20.44%
Return on Capital Employed (ROCE)	-3.20%	-3.80%	-4.30%	-4.20%	-3.30%	-6.70%
Earnings Yield	30.67%	17.29%	12.16%	-227.18%	50.51%	-17.79%
FCF Yield	-4.36%	-0.13%	-1.15%	-22.55%	-5.06%	-3.34%
Buyback Yield / Dilution	0.04%	-17.33%	-134.70%	-21.34%	-44.57%	6.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.